The use of epitope arrays in immunodiagnosis of infectious disease: Hepatitis C virus, a case study

Analytical Biochemistry

Volumn 432, Issue 2, 2013, Pages 63-70

  Siman Tov, Dror D ^a   Zemel, Romy ^a   Tur Kaspa, Ran ^a,b   Gershoni, Jonathan M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Antibody serodiagnostics; Combinatorial diagnostics; HCV serotyping; Peptide epitopes; Phage display

Indexed keywords

ANTIBODIES; CHEMICAL DETECTION; DIAGNOSIS; DISEASES; MIXTURES; PHAGE DISPLAY; VIRUSES;

CONFORMATIONAL EPITOPES; ENZYME IMMUNOASSAY; HEPATITIS C VIRUS; IMMUNODIAGNOSIS; INFECTIOUS DISEASE; PEPTIDE EPITOPES; SEROTYPING; SOLID-PHASE IMMUNOASSAY;

EPITOPES;

EPITOPE; VIRUS ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; PHAGE DISPLAY; PRIORITY JOURNAL; SERODIAGNOSIS; SEROTYPING; WESTERN BLOTTING;

HEPATITIS C VIRUS;

EID: 84868522369     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2012.09.025     Document Type: Article

References (46)

1. P. Hornbeck Enzyme-linked immunosorbent assays Curr. Protoc. Immunol. 2001 unit 2.1
2. A.H. Peruski, and L.F. Peruski Jr. Immunological methods for detection and identification of infectious disease and biological warfare agents Clin. Diagn. Lab. Immunol. 10 2003 506 513
3. B.T. Kurien, Y. Dorri, S. Dillon, A. Dsouza, and R.H. Scofield An overview of Western blotting for determining antibody specificities for immunohistochemistry Methods Mol. Biol. 717 2011 55 67
4. D.J. MacPhee Methodological considerations for improving Western blot analysis J. Pharmacol. Toxicol. Methods 61 2010 171 177
5. A. Alegria-Schaffer, A. Lodge, and K. Vattem Performing and optimizing Western blots with an emphasis on chemiluminescent detection Methods Enzymol. 463 2009 573 599
6. W.J. Maskill, C. Silvester, and D.S. Healey Application of protein blotting to the serodiagnosis of human immunodeficiency virus infection B.A. Baldo, E.R. Tovey, N.S.W. St. Leonards, Protein Blotting 1989 Karger Basel, Switzerland 69 95
7. J.M. Gershoni Protein-blot analysis of receptor-ligand interactions Biochem. Soc. Trans. 16 1988 138 139
8. S.L. Chen, and T.R. Morgan The natural history of hepatitis C virus (HCV) infection Int. J. Med. Sci. 3 2006 47 52
9. D. Moradpour, F. Penin, and C.M. Rice Replication of hepatitis C virus Nat. Rev. Microbiol. 5 2007 453 463
10. F. Penin, J. Dubuisson, F.A. Rey, D. Moradpour, and J.M. Pawlotsky Structural biology of hepatitis C virus Hepatology 39 2004 5 19
11. M. Houghton The long and winding road leading to the identification of the hepatitis C virus J. Hepatol. 51 2009 939 948
12. H. Tang, and H. Grise Cellular and molecular biology of HCV infection and hepatitis Clin. Sci. (Lond.) 117 2009 49 65
13. D. Enshell-Seijffers, L. Smelyanski, and J.M. Gershoni The rational design of a "type 88" genetically stable peptide display vector in the filamentous bacteriophage fd Nucleic Acids Res. 29 2001 e50
14. N.T. Freund, D. Enshell-Seijffers, and J.M. Gershoni Phage display selection, analysis, and prediction of B cell epitopes Curr. Protoc. Immunol. 2009 unit 9.8
15. L. Smelyanski, and J.M. Gershoni Site directed biotinylation of filamentous phage structural proteins Virol. J. 8 2011 495
16. P. Ferroni, G. Mascolo, M. Zaninetti, D. Colzani, F. Pregliasco, M. Pirisi, F. Barbone, and V. Gasparini Identification of four epitopes in hepatitis C virus core protein J. Clin. Microbiol. 31 1993 1586 1591
17. C. Ishida, K. Matsumoto, K. Fukada, K. Matsushita, H. Shiraki, and Y. Maeda Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens J. Clin. Microbiol. 31 1993 936 940
18. C. Jolivet-Reynaud, P. Dalbon, F. Viola, S. Yvon, G. Paranhos-Baccala, N. Piga, L. Bridon, M.A. Trabaud, N. Battail, G. Sibai, and M. Jolivet HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection J. Med. Virol. 56 1998 300 309
19. E. Khudyakov Yu, N.S. Khudyakova, D.L. Jue, S.B. Lambert, S. Fang, and H.A. Fields Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides Virology 206 1995 666 672
20. R. Menez, M. Bossus, B.H. Muller, G. Sibai, P. Dalbon, F. Ducancel, C. Jolivet-Reynaud, and E.A. Stura Crystal structure of a hydrophobic immunodominant antigenic site on hepatitis C virus core protein complexed to monoclonal antibody 19D9D6 J. Immunol. 170 2003 1917 1924
21. O. Minenkova, N. Gargano, A. De Tomassi, F. Bellintani, A. Pucci, P. Fortugno, E. Fuscaldi, A. Pessi, M. Rapicetta, M. Miceli, P. Iudicone, R. Cortese, F. Felici, and P. Monaci ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serum Eur. J. Biochem. 268 2001 4758 4768
22. A. Palacios, L. Taylor, L. Haue, R.B. Luftig, and K.A. Visona Development of low cost peptide-based anti-hepatitis C virus screening and confirmatory assays: comparison with commercially available tests J. Med. Virol. 58 1999 221 226
23. L.A. Pereboeva, A.V. Pereboev, and G.E. Morris Identification of antigenic sites on three hepatitis C virus proteins using phage-displayed peptide libraries J. Med. Virol. 56 1998 105 111
24. L.A. Pereboeva, A.V. Pereboev, L.F. Wang, and G.E. Morris Hepatitis C epitopes from phage-displayed cDNA libraries and improved diagnosis with a chimeric antigen J. Med. Virol. 60 2000 144 151
25. C. Prezzi, M. Nuzzo, A. Meola, P. Delmastro, G. Galfre, R. Cortese, A. Nicosia, and P. Monaci Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients J. Immunol. 156 1996 4504 4513
26. M. Sallberg, U. Ruden, B. Wahren, and L.O. Magnius Immunodominant regions within the hepatitis C virus core and putative matrix proteins J. Clin. Microbiol. 30 1992 1989 1994
27. M. Sallberg, U. Ruden, B. Wahren, and L.O. Magnius Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: the isotypes and the recognition site Immunol. Lett. 33 1992 27 33
28. D.D. Siman-Tov, L. Navon-Perry, N.L. Haigwood, and J.M. Gershoni Differentiation of a passive vaccine and the humoral immune response toward infection: analysis of phage displayed peptides Vaccine 24 2006 607 612
29. H. Claeys, A. Volckaerts, W. Mertens, Z. Liang, P. Fiten, and G. Opdenakker Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus J. Med. Virol. 45 1995 273 281
30. C. Jolivet-Reynaud, A. Adida, S. Michel, G. Deleage, G. Paranhos-Baccala, V. Gonin, N. Battail-Poirot, X. Lacoux, and D. Rolland Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase J. Med. Virol. 72 2004 385 395
31. M.U. Mondelli, A. Cerino, P. Boender, P. Oudshoorn, J. Middeldorp, C. Fipaldini, N. La Monica, and W. Habets Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody J. Virol. 68 1994 4829 4836
32. G. Dusheiko, and P. Simmonds Sequence variability of hepatitis C virus and its clinical relevance J. Viral Hepat. 1 1994 3 15
33. K. Hino, S. Sainokami, K. Shimoda, S. Iino, Y. Wang, H. Okamoto, Y. Miyakawa, and M. Mayumi Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C J. Med. Virol. 42 1994 299 305
34. U. Hopf, T. Berg, V. Konig, S. Kuther, H.G. Heuft, and H. Lobeck Treatment of chronic hepatitis C with interferon-α: long-term follow-up and prognostic relevance of HCV genotypes J. Hepatol. 24 1996 67 73
35. A. Tsubota, K. Chayama, K. Ikeda, A. Yasuji, I. Koida, S. Saitoh, M. Hashimoto, S. Iwasaki, M. Kobayashi, and K. Hiromitsu Factors predictive of response to interferon-α therapy in hepatitis C virus infection Hepatology 19 1994 1088 1094
36. G.L. Davis, and J.Y. Lau Factors predictive of a beneficial response to therapy of hepatitis C Hepatology 26 1997 122S 127S
37. N.N. Zein, J. Rakela, E.L. Krawitt, K.R. Reddy, T. Tominaga, and D.H. Persing Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy - Collaborative Study Group Ann. Intern. Med. 125 1996 634 639
38. P.S. Pang, P.J. Planet, and J.S. Glenn The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy PLoS One 4 2009 e6579
39. S.S. Richter Laboratory assays for diagnosis and management of hepatitis C virus infection J. Clin. Microbiol. 40 2002 4407 4412
40. G. Kuo, Q.L. Choo, H.J. Alter, G.L. Gitnick, A.G. Redeker, R.H. Purcell, T. Miyamura, J.L. Dienstag, M.J. Alter, and C.E. Stevens An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis Science 244 1989 362 364
41. E. Kolho Specificity and sensitivity of first and second generation anti-HCV ELISA in a low prevalence population Transfus. Med. 2 1992 239 242
42. P. Martin, F. Fabrizi, V. Dixit, S. Quan, M. Brezina, E. Kaufman, K. Sra, R. DiNello, A. Polito, and G. Gitnick Automated RIBA hepatitis C virus (HCV) strip immunoblot assay for reproducible HCV diagnosis J. Clin. Microbiol. 36 1998 387 390
43. O. Minenkova, A. Pucci, E. Pavoni, A. De Tomassi, P. Fortugno, N. Gargano, M. Cianfriglia, S. Barca, S. De Placido, A. Martignetti, F. Felici, R. Cortese, and P. Monaci Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients Int. J. Cancer 106 2003 534 544
44. O.O. Minenkova, A.A. Ilyichev, G.P. Kishchenko, and V.A. Petrenko Design of specific immunogens using filamentous phage as the carrier Gene 128 1993 85 88
45. Y. Shemer-Avni, Z. el Astal, O. Kemper, K.J. el Najjar, A. Yaari, N. Hanuka, M. Margalith, and E. Sikuler Hepatitis C virus infection and genotypes in southern Israel and the Gaza Strip J. Med. Virol. 56 1998 230 233
46. Y. Maor, D. Bashari, G. Kenet, S. Lalezari, A. Lubetsky, J. Luboshitz, J.M. Schapiro, B. Avidan, S. Bar-Meir, and U. Martinowitz Hepatitis C at the israeli national hemophilia center Haemophilia 12 2006 68 74